- Home
- PAVS vs OLMA Comparison
PAVS vs OLMA Comparison
Compare PAVS & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- OLMA
- Stock Information
- Founded
- PAVS 2004
- OLMA 2006
- Country
- PAVS United States
- OLMA United States
- Employees
- PAVS N/A
- OLMA N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- OLMA Health Care
- Exchange
- PAVS Nasdaq
- OLMA Nasdaq
- Market Cap
- PAVS 61.9M
- OLMA 465.4M
- IPO Year
- PAVS 2019
- OLMA 2020
- Fundamental
- Price
- PAVS $1.36
- OLMA $6.10
- Analyst Decision
- PAVS
- OLMA Strong Buy
- Analyst Count
- PAVS 0
- OLMA 5
- Target Price
- PAVS N/A
- OLMA $26.25
- AVG Volume (30 Days)
- PAVS 58.0K
- OLMA 1.1M
- Earning Date
- PAVS 01-09-2025
- OLMA 11-12-2024
- Dividend Yield
- PAVS N/A
- OLMA N/A
- EPS Growth
- PAVS N/A
- OLMA N/A
- EPS
- PAVS N/A
- OLMA N/A
- Revenue
- PAVS $6,544,819.00
- OLMA N/A
- Revenue This Year
- PAVS N/A
- OLMA N/A
- Revenue Next Year
- PAVS N/A
- OLMA N/A
- P/E Ratio
- PAVS N/A
- OLMA N/A
- Revenue Growth
- PAVS N/A
- OLMA N/A
- 52 Week Low
- PAVS $0.32
- OLMA $5.56
- 52 Week High
- PAVS $2.97
- OLMA $16.78
- Technical
- Relative Strength Index (RSI)
- PAVS 75.67
- OLMA 27.05
- Support Level
- PAVS $1.03
- OLMA $5.56
- Resistance Level
- PAVS $1.45
- OLMA $6.87
- Average True Range (ATR)
- PAVS 0.10
- OLMA 0.81
- MACD
- PAVS 0.05
- OLMA -0.28
- Stochastic Oscillator
- PAVS 83.32
- OLMA 10.12
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.